2018 was a strong year for pharmaceutical stocks, more specifically small-cap pharma stocks. Neos Therapeutics, Inc. (NASDAQ:NEOS), however, was not among that group and performed extremely poorly in 2018.
Today, NEOS stock is making quite the comeback, up +20%. Will today’s company news keep the stock green for a while? Let’s find out!
Neos Therapeutics Reports Q4 and Full 2018 EarningsNeos Therapeutics released its Q4 and full 2018 earnings today and investors seem thrilled with the company’s turnaround. The pharmaceutical company’s three commercial ADHD products showed continued growth for the year. Its Cotempla ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.